Skip to main content

Feature article – US agrochemicals: A delicate balance

15th July 2024

Submitted by:

Andrew Warmington

Price pressure stalls re-shoring in US agrochemicals, but business was brisk with positive energy at the Specialty & Agro Chemicals America event. Gregory D.L. Morris reports from Savannah

“Ag prices are down and farmers are hurting,” said Jim DeLisi, president of Fanwood Chemical, in his outlook briefings at the Specialty & Agro Chemicals America conference on 25-28 June in Savannah, Georgia. “There are huge inventories, especially of corn, and the situation could be getting worse. That means reduced use of fertilisers and other ag chems. And when they are used, there is the financial pressure to use generics.” These are already about 70% of the market.

The other major topic at the conference was what became of shorter, more robust supply chains. “After the pandemic it seemed like everyone was talking about re-shoring or near-shoring,” said Franklin J. Fisher, president of SC Chem. “But people forgot, or got lazy. If you look around today, China is winning on price and volume. India is winning. Europe is losing. BASF is shutting sites at Ludwigshafen.”

Several speakers noted the importance of BASF as a bellwether for the European chemical industry. A few noted the irony that Germany was the cradle of many agricultural chemicals, dyestuffs and other speciality chemicals. Fisher’s counterpart, Jim Stavrakas, managing director of PFP Commercial Consulting, suggested that, “near-shoring got replaced by geographic diversity in supply”. While acknowledging the headwinds, delegates at the conference maintained a positive outlook.

The exhibit floors were full, as the social areas and meeting rooms were loud with conversation. Beyond the usual cycles of commodity prices DeLisi expressed concern that “the zenith of agchems is now. Drone technology allows farmers to find and spot apply as needed: herbicide here, fungicide there, insecticide over there. There will be less need for broad-area application. Environmentally there is no argument, and economically, for the farmer, there is no argument.”

This means reductions in total volumes throughout the value chain. In the near term, however, another glyphosate crash could be on the cards. “That is a key herbicide import,” said DeLisi, “and production from China is growing.”

Along the same lines, prices of 2,4-dichlorophenoxyacetic acid (2,4-D) have fallen by half in the last two years, mostly due to imports from China, DeLisi stated. In April the US Department of Commerce initiated an anti-dumping and countervailing duty investigation regarding 2,4-D from China and India.

“As many of you have noted, the fall in prices for 2,4-D just puts them back to where they were,” said DeLisi. “But historical prices are not considered in anti-dumping investigations. The timeframe is from when the investigation begins. The case should be concluded by the end of the year.” His strong feeling is that there will be some anti-dumping finding, especially because the investigation would have ended at an earlier stage if there were no grounds for proceeding.

Regardless of the findings in that one case, China has many significant strengths, DeLisi related. “It has 170 bilateral investment treaties, including some with European countries. It also has 17 free trade agreements.” That is a very big lever when negotiating trade terms with other countries and blocs.  China also seems to be playing both sides of the street, DeLisi noted. “The second largest economy in the world is still a ‘developing country’ in the WTO.” More specifically, a major point of concern in the US is that at least 70% of all agrochemicals have a Chinese component – and it could be as high as 80%.

One of the quiet shifts in the US agrochemical sector is the increasing portion of land under cultivation that is used to grow fuel rather than food. According to DeLisi, 45% of all the corn grown in the US is used to make ethanol for fuel. The same portion of soy oil is used in biofuels. How those percentages progress in the next few years, especially as electric vehicles gain market share, remains to be seen. There is less uncertainty about the prospects for shorter, more robust supply chains.

One toll manufacturing executive lamented that, “on-shoring and near-shoring are mostly just posturing. Orders are still going to suppliers in Asia who pay their workers a dollar a day in some places, and have little compliance. Labour rates in the US are $20-30/hour and we have to meet OSHA and EPA regulations.” Even when orders are offered to North American or European producers, the volumes tend to be small.

“The only significant shift we’ve seen in purchasing policy is that clients have opened about 20% of what was their single-source orders,” said a senior executive of a large toll manufacturer. “But even then, that 20% is not to one or two other suppliers, it’s scattered around to a dozen or more, so everyone just gets a sliver. Those are only the ones who are still willing to meet the price and terms of the main supplier even for that little sliver.”

Fisher related a common scenario. “Your CFO says he needs every nickel. You say there is a cost associated with having a single source. He says ‘Do it anyway’. If that happens, you should get it in writing from him so you can show it at the meeting when something goes wrong with that single source.” Another scenario could be “your competition rolls the dice and stays with a single source. So then they gain volume or market share.”

Putting those situations into context Stavrakas said that, “it is important for your financial leadership to understand what is going on with the worldwide chemical industry in general and supply chains in particular. Very few understand the industry. You have to explain it to them. For example, the process for qualifying suppliers can vary all over the board.” The key, Fisher, explained, “is to get them to listen to the narrative, not just look at the numbers. If you have to go with a single source, ask what Plan B is and – very important – what the timeline for it is. That is how much inventory you have to have on hand.”

Toll Solutions has added two 4,000-gallon reactors at its manufacturing complex in Duncan, South Carolina. “We are always exploring expansion, whether that is organically or through acquisition,” said Joseph Wilson, Jr., president and CEO. The Duncan site is operating around the clock five days a week and would like to go to 24/7.

“That was one of my goals in going to Chemspec Europe,” said Wilson, “to find European companies that want to produce in the US Re-shoring is an opportunity for them. Part of their frustration is regulation. “That is why the work of SOCMA is so important,” Wilson continued. “I was on Capitol Hill earlier in June as part of our efforts to educate legislators. Re-shoring presents a great opportunity, but regulation is hurting innovation.”

Citing Pre-Manufacturing Notices and the Toxic Substance Control Act Wilson said: “The system is broken. That is going to hurt us as a country.” Nevertheless, Toll Solutions is growing. “Business has been very steady for a few years,” said Wilson. “There is more outsourcing than in the past. People seem to want to producer less and outsource more.”

Actylis is also expanding. Early in 2023 it opened a new manufacturing facility for APIs at Eugene, Oregon. Since then there have been expansions completed or planned for its other North American research and manufacturing complexes: Buffalo, New York; Ogden, Utah; and Montreal.

Packaging is also in flux as global supply chains are revised, which adds a wrinkle for packaging materials themselves. “As governments and companies set their sustainability goals fro 2030, 2050 and beyond, they have to consider how that is going to affect companies up and down the supply chain,’ said Jane Matyac, manager of strategic marketing at container manufacturer Greif. The firm recently opened a new manufacturing plant in Dallas, and completed the $538-million acquisition of Ipackchem Group, an international maker of small, rigid plastic containers.

Feature article – Saltigo rides out the cycle

Market and sustainability trends are positive drivers for Saltigo, despite the agro downturn. Andrew Warmington met up with the new CEO at Chemspec Europe

Submitted by:

Andrew Warmington

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical active ingredient (AI) manufacturing to its wholly owned subsidiary UPL Spec

Submitted by:

Andrew Warmington

Nippon Shokubai opens Indonesian plant

Japan’s Nippon Shokubai has officially opened a 100,000 tonnes/year acrylic acid (AA) plant that was built at a cost of about $200 million at Cilegon, Banten, Indonesia.

Submitted by:

Andrew Warmington

CABB to invest at Finnish agro site

The CABB Group has said that it will invest over €50 million by 2025 to expand facilities at its agrochemical manufacturing site in Kokkola, Finland.

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production planning of superabsorbent polymers (SAPs) based on acrylic acid, and has started operati

Submitted by:

Andrew Warmington

adcs

Three invest further into ADCs

Three CDMOs have separately announced expansions in their antibody-drug conjugate (ADC) manufacturing capabilities and capacity on opposite sides of the Atlantic.

Submitted by:

Andrew Warmington

Cambrex exits drug product

CDMO Cambrex has sold its Drug Product business unit to Noramco. Terms were not disclosed.

Submitted by:

Andrew Warmington

Siegfried breaks ground on R&D centre

Siegfried has broke ground for its new global R&D centre for drug substances at its site in Evionnaz, Switzerland.

Submitted by:

Andrew Warmington

Drug product centre opens

Following two years of construction work, CDMO Siegfried has officially opened its new development centre for drug products at its sites in Barberà del Vallès and El Masnou near Barcelona.

Submitted by:

Andrew Warmington

Evonik realigns Health Care

In order to “maximise customer centricity and market focus” and continue an ongoing transition into “a system solutions partner for the pharmaceutical and biotech industries”, Evonik has divided it

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants under the trade names AmphiCare and AmphiClean.

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based subsidiary of Seqens.

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in Austria have co-developed a computer-assisted regression model to improve enzyme performance and

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU and the Bio-based Industries Consortium (BIC) that funds projects advancing competitive circular bi

Submitted by:

Andrew Warmington

Investment in Tanasote plant

Octowood, a part of the Sweden’s Rundvirke Industrier Group, has invested in a new treatment plant using Arxada’s wood preservative, Tanasote.

Submitted by:

Andrew Warmington

Rhamnolipid milestone reached

Evonik has manufactured the first product from its industrial-scale biosurfactants facility at Slovenská Lupca in Slovakia.

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach Group in a move that it said would “create a global pigment company, combining SCIL’s ope

Submitted by:

Andrew Warmington

Lanxess to continue pigment production

Lanxess has reversed a decision to sell the chromium oxide pigments business at the Krefeld-Uerdingen site in Germany, preserving 50 jobs there.

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw materials, has announced a strategic collaboration with Japan’s Takasago, a large player in th

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site in Guangzhou. This triples its manufacturing capacity for fragrances and establis

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable fragrance ingredients from renewable carbon, with US-based LanzaTech, which describes i

Submitted by:

Andrew Warmington

Kao boosts jasmine fragrance

Japan's Kao Corporation is to double capacity for the synthetic fragrance methyl dihydrojasmonate (MDJ) at its site in Olesa, Spain, by adding a second production facility.

Submitted by:

Andrew Warmington

Merck KGaA “in a strong strategic position”

At its latest Capital Markets Day, Merck KGaA said that it is “in a strong strategic position” to profit from medium-term growth opportunities in all three of its business sectors after a transitio

Submitted by:

Andrew Warmington

Suez joins Global Impact Coalition

Suez, which describes itself as “a global leader in circular solutions for water and waste”, has joined the Global Impact Coalition (GIC).

Submitted by:

Andrew Warmington

Chemours opens battery lab

Chemours has opened Chemours Battery Innovation Centre (CBIC) at the Chemours Discovery Hub in Newark, Delaware.

Submitted by:

Andrew Warmington